EUVIMEDEUVIMED entdecken
Crossref

n-Butanol fraction from Hedysarum alpinum L. attenuates scopolamine-induced memory impairment in rats

Aldarmaa Jalsrai, Anu Altangerel, Myadagbadam Urtnasan, Saranchimeg Borchuluun, Kristina Battsogt, Yue Cong, Hsiu Mei Hsieh-Li

Journal of Herbmed Pharmacology · 01.07.2026 · 15 (3) · 372-378

DOI: 10.34172/jhp.53652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Herbmed Pharmacology, online erschienen am 01.07.2026. Verfasst von Aldarmaa Jalsrai und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hedysarum alpinum L. (HA) contains considerable amounts of polyphenols and saponins, and exhibits immune-enhancing and antiviral properties. Evidence indicates that triterpenoid saponins possess neuroprotective effects against neurodegenerative damage. The present study evaluated the effect of an HA saponin-rich n-butanol fraction (HABF) on cognitive deficits induced by scopolamine in a rat model.

Methods

Cognitive impairment was assessed using passive avoidance (PA) and novel object recognition (NOR) tasks. Total triterpene saponins of HABF were quantified by the colorimetric method using oleanolic acid as a standard compound. Biochemical analyses of hippocampus tissue included measurements of acetylcholinesterase (AChE) activity, choline acetyltransferase (ChAT), catalase (CAT), and tumor necrosis factor-α (TNF-α).

Results

HABF contained 131 ± 0.02 mg oleanolic acid equivalent (OAE)/g of total triterpene saponins. Scopolamine significantly impaired memory, as shown by a decreased discrimination index in the NOR test and reduced retention latency in the PA test. Pretreatment with HABF (40 and 80 mg/kg) significantly alleviated the memory deficits in both tasks. Scopolamine significantly increased AChE activity and TNF-α levels, and decreased CAT activity compared to the vehicle-treated group. These alterations were significantly reversed by HABF treatment, whereas ChAT activity remained unchanged compared with the MPTP-treated group.

Conclusion

HABF, rich in triterpene saponins, ameliorates scopolamine-induced memory impairment, likely through the inhibition of AChE activity and modulation of oxidative stress and inflammation. These findings may suggest its potential neuroprotective effect in cognitive dysfunction.

Zitieren

APA

Jalsrai, A., Altangerel, A., Urtnasan, M., Borchuluun, S., Battsogt, K., Cong, Y., & Hsieh-Li, H. M. (2026). n-Butanol fraction from Hedysarum alpinum L. attenuates scopolamine-induced memory impairment in rats. Journal of Herbmed Pharmacology, 15(3), 372-378. https://doi.org/10.34172/jhp.53652

Vancouver

Jalsrai A, Altangerel A, Urtnasan M, Borchuluun S, Battsogt K, Cong Y, et al. n-Butanol fraction from Hedysarum alpinum L. attenuates scopolamine-induced memory impairment in rats. Journal of Herbmed Pharmacology. 2026;15(3):372-378. doi:10.34172/jhp.53652

BibTeX
@article{Jalsrai2026,
  author = {Jalsrai, Aldarmaa and Altangerel, Anu and Urtnasan, Myadagbadam and Borchuluun, Saranchimeg and Battsogt, Kristina and Cong, Yue and Hsieh-Li, Hsiu Mei},
  title = {n-Butanol fraction from Hedysarum alpinum L. attenuates scopolamine-induced memory impairment in rats},
  journal = {Journal of Herbmed Pharmacology},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {372--378},
  doi = {10.34172/jhp.53652}
}
Kostenlos starten →